Biblio
Export 1382 results:
Author Title [ Type
Filters: First Letter Of Last Name is G [Clear All Filters]
“Plasma Screening for Progranulin Mutations in Patients with Progressive Supranuclear Palsy and Corticobasal Syndromes.”, J Alzheimers Dis, vol. 53, no. 2, pp. 445-9, 2016.
, “Plasma Proteomic Profiles of Cerebrospinal Fluid-Defined Alzheimer's Disease Pathology in Older Adults.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1641-1652, 2017.
, “Plasma Phospholipid and Sphingolipid Alterations in Presenilin1 Mutation Carriers: A Pilot Study.”, J Alzheimers Dis, vol. 50, no. 3, pp. 887-94, 2016.
, “Plasma Neurofilament Light Chain Predicts Cognitive Progression in Prodromal and Clinical Dementia with Lewy Bodies.”, J Alzheimers Dis, vol. 82, no. 3, pp. 913-919, 2021.
, “Plasma High Density Lipoprotein Small Subclass is Reduced in Alzheimer's Disease Patients and Correlates with Cognitive Performance.”, J Alzheimers Dis, vol. 77, no. 2, pp. 733-744, 2020.
, “Plasma Biomarkers of Alzheimer's Disease in African Americans.”, J Alzheimers Dis, vol. 79, no. 1, pp. 323-334, 2021.
, “PKC Activation Counteracts ADAM10 Deficit in HuD-Silenced Neuroblastoma Cells.”, J Alzheimers Dis, vol. 54, no. 2, pp. 535-47, 2016.
, “Pink1 Regulates Tyrosine Hydroxylase Expression and Dopamine Synthesis.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1361-1371, 2018.
, “PICALM Gene Methylation in Blood of Alzheimer's Disease Patients Is Associated with Cognitive Decline.”, J Alzheimers Dis, vol. 65, no. 1, pp. 283-292, 2018.
, “The PI3K/AKT Signaling Pathway and Caspase-3 in Alzheimer's Disease: Which One Is the Beginner?”, J Alzheimers Dis, vol. 92, no. 2, pp. 391-393, 2023.
, “Physical Activity in Midlife is not Associated with Cognitive Health in Later Life Among Cognitively Normal Older Adults.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1349-1358, 2017.
, “Physical Activity in Midlife is not Associated with Cognitive Health in Later Life Among Cognitively Normal Older Adults.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1349-1358, 2017.
, “Physical Activity and Trajectory of Cognitive Change in Older Persons: Mayo Clinic Study of Aging.”, J Alzheimers Dis, vol. 79, no. 1, pp. 377-388, 2021.
, “Phenotype-Dependent Interactions between N-acetyl-L-Aspartate and Acetyl-CoA in Septal SN56 Cholinergic Cells Exposed to an Excess of Zinc.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1145-1158, 2017.
, “Phenotype-Dependent Interactions between N-acetyl-L-Aspartate and Acetyl-CoA in Septal SN56 Cholinergic Cells Exposed to an Excess of Zinc.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1145-1158, 2017.
, “A Phase IIa Randomized Control Trial of VEL015 (Sodium Selenate) in Mild-Moderate Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 1, pp. 223-32, 2016.
, “A Phase II Study of Fornix Deep Brain Stimulation in Mild Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 2, pp. 777-87, 2016.
, “PET Tau and Amyloid-β Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers.”, J Alzheimers Dis, vol. 60, no. 1, pp. 283-293, 2017.
, “Perspectives on Communicating Biomarker-Based Assessments of Alzheimer's Disease to Cognitively Healthy Individuals.”, J Alzheimers Dis, vol. 62, no. 2, pp. 487-498, 2018.
, “Perspectives on Communicating Biomarker-Based Assessments of Alzheimer's Disease to Cognitively Healthy Individuals.”, J Alzheimers Dis, vol. 62, no. 2, pp. 487-498, 2018.
, “Personality Modulates the Efficacy of Art Intervention on Chronic Pain in a Population of Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 63, no. 2, pp. 617-624, 2018.
, “Perlecan Domain V Inhibits Amyloid-β Induced Activation of the α2β1 Integrin-Mediated Neurotoxic Signaling Cascade.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1629-1647, 2016.
, “Performance of Validated MicroRNA Biomarkers for Alzheimer's Disease in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 78, no. 1, pp. 245-263, 2020.
, “Performance of a smell identification test versus the Mini-Mental Status Exam for the detection of dementia and cognitive impairment among persons with cognitive concerns in primary care.”, J Alzheimers Dis, p. 13872877251345083, 2025.
, “Perceived Stress is Associated with Alzheimer's Disease Cerebrospinal Fluid Biomarkers in African Americans with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 77, no. 2, pp. 843-853, 2020.
,